
Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 1 chart position in 1 market.
By chart position
- 🇨🇦CA · Medicine#1485K to 30K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
2.5K to 15K🎙 ~2x weekly·89 episodes·Last published 3w ago - Monthly Reach
Unique listeners across all episodes (30 days)
5K to 30K🇨🇦100% - Active Followers
Loyal subscribers who consistently listen
2K to 12K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 11 epsHosts
Not detected.
Recent guests
Recent episodes
Why Healthcare Leadership Is Harder Than Ever: Cedars-Sinai’s Tom Priselac on Culture, Change and Cost
May 28, 2026
39m 19s
A Giant Leap for Healthcare: Dr. Bob Wachter on AI, Clinical Workflows and the Patient-Doctor Relationship
Apr 16, 2026
46m 44s
From Pilots to Production: Boston Children’s John Brownstein on the Next Phase of AI in Healthcare
Mar 19, 2026
42m 45s
DC’s Ambitious Plans for Modernizing Health Tech: U.S. DOGE Service Administrator & CMS Strategic Advisor, Amy Gleason
Feb 19, 2026
38m 35s
Glimmers of Nonpartisan Progress: Decoding ACCESS, TEMPO and the Latest Government Healthcare Initiatives
Jan 15, 2026
46m 40s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 5/28/26 | ![]() Why Healthcare Leadership Is Harder Than Ever: Cedars-Sinai’s Tom Priselac on Culture, Change and Cost✨ | healthcare leadershiporganizational culture+3 | Tom Priselac | Cedars-Sinai | — | healthcareleadership+5 | — | 39m 19s | |
| 4/16/26 | ![]() A Giant Leap for Healthcare: Dr. Bob Wachter on AI, Clinical Workflows and the Patient-Doctor Relationship✨ | AIclinical workflows+2 | Dr Bob Wachter | — | — | hospitalisthealthcare organization+1 | — | 46m 44s | |
| 3/19/26 | ![]() From Pilots to Production: Boston Children’s John Brownstein on the Next Phase of AI in Healthcare✨ | AI in healthcaredigital health+2 | Dr John Brownstein | Google Flu Trendsdata analytics companies+3 | — | Boston Children’sGoogle Flu Trends+3 | — | 42m 45s | |
| 2/19/26 | ![]() DC’s Ambitious Plans for Modernizing Health Tech: U.S. DOGE Service Administrator & CMS Strategic Advisor, Amy Gleason✨ | health techelectronic health records+2 | Amy Gleason | electronic health recordsDC+2 | — | healthcaretechnology+2 | — | 38m 35s | |
| 1/15/26 | ![]() Glimmers of Nonpartisan Progress: Decoding ACCESS, TEMPO and the Latest Government Healthcare Initiatives✨ | data exchangeinteroperability+2 | Ryan Howells | — | — | patient experiencestechnology+2 | — | 46m 40s | |
| 12/18/25 | ![]() 340B Unpacked for the Holidays: Policy, Controversy, and Impact✨ | 340B drug discount programhealthcare policy+2 | — | 340B | — | healthcarepharmacy+2 | — | 35m 07s | |
| 11/20/25 | ![]() The Big Beautiful Maze of Health Policy and Innovation✨ | health policyinnovation+3 | Liz Fowler | the Center for Medicare and Medicaid InnovationCMMI+1 | U.S. | healthcarepolicy shifts+2 | — | 32m 28s | |
| 10/16/25 | ![]() Lessons from Public Sector Leadership: Former CMS Administrator and FDA Commissioner, Dr. Mark McClellan✨ | healthcare policyleadership+2 | Dr Mark Mcclellan | CMSFDA+3 | — | CMSFDA+3 | — | 48m 10s | |
| 9/18/25 | ![]() Emerging Technologies (Part 3): Microsoft’s Chief Architect for Health on the Saga of Interoperability and AI✨ | emerging technologiesinteroperability+3 | Dr Josh Mandel | MicrosoftMIT+1 | Boston | Microsofthealth+2 | — | 48m 06s | |
| 8/21/25 | ![]() Emerging Technologies (Part 2): Past, Present & Future of Healthcare Interoperability with HTD Health's Brendan Keeler✨ | healthcare interoperabilityemerging technologies+1 | Brendan Keeler | EpicRedox+6 | U.S.Europe | EpicRedox+3 | — | 49m 12s | |
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 7/17/25 | ![]() Emerging Technologies (Part 1): Inside Perspectives from Epic’s Seth Hain✨ | emerging technologieselectronic health records+2 | Seth Hain | EpicInside Perspectives from Epic’s Seth | — | care-delivery platformagentic era+1 | — | 49m 02s | |
| 6/19/25 | ![]() How a Tech-Minded CEO Sees the Future: CareFirst’s Brian D. Pieninck on Medicare, Medicaid & the AI-Driven Inflection Point in Healthcare | Brian D. Pieninck didn’t take a conventional path to healthcare leadership. He started his career as an 18-year-old IT contractor and spent two decades working across the industry before becoming President and CEO of CareFirst Blue Cross Blue Shield. He now also serves as Chair of the Blue Cross Blue Shield Association, bringing both local and national perspective to the role. In this episode, Keith Figlioli speaks with Pieninck about what it means to lead a not-for-profit regional paye... | 45m 17s | ||||||
| 5/15/25 | ![]() Medicaid Uncovered: Decoding the System | Kody Kinsley has been called many things—operator, innovator, Medicaid “nerd”—but above all, he’s a fierce advocate for the health and well-being of the populations Medicaid serves. Now a senior advisor at the Milken Institute and recently North Carolina’s Secretary of Health and Human Services, Kinsley joins Keith Figlioli for a wide-ranging conversation about how Medicaid works, why it matters, and where innovation is reshaping its future. A native of North Carolina, Kinsley brings pe... | 44m 57s | ||||||
| 4/29/25 | ![]() Where Medicare Stands—And Where It’s Headed with Aetna’s Dr. Ali Khan | Dr. Ali Khan has spent his career at the intersection of medicine, public policy, and value-based care. He’s also been at the forefront of some of the country's most innovative care delivery models—from Iora Health and CareMore to Oak Street Health and now Aetna, where he serves as Chief Medical Officer of Medicare at Aetna, a CVS Health company. In this episode, Keith Figlioli sits down with Dr. Khan for a conversation about Medicare’s future—and what it will take to make the promise of bett... | 49m 25s | ||||||
| 3/20/25 | ![]() Opportunities in Oncology (Part 3): Getting Deep Into Patient Care with Mass General Brigham’s Head of Radiation Oncology | The first two episodes in this Healthcare is Hard podcast series on “Opportunities in Oncology” explored the relationship between academic medical centers and community care, with guests Dr. Stephen Schleicher from Tennessee Oncology, and Dr. Harlan Levine from City of Hope. For the third and final episode in the series, Dr. Daphne Haas-Kogan joined Keith Figlioli for a conversation that dives more deeply into patient care, innovations in care delivery and the opportunities for entrepreneurs.... | 37m 19s | ||||||
| 2/20/25 | ![]() Opportunities in Oncology (Part 2): Balancing Cutting-Edge Research and Community Care | Dr. Harlan Levine began his career practicing internal medicine but soon moved into business leadership roles at national healthcare organizations to help improve the dysfunction with payer-provider relationships that he experienced firsthand as a physician. At United Health Group, Dr. Levine joined as clinical lead of the team that launched Optum, where he subsequently served as chief medical officer for more than six years. He also led the health management practice at Towers Watson and ser... | 40m 47s | ||||||
| 1/23/25 | ![]() Opportunities in Oncology (Part 1): The Intersection of Clinical Care, Business and Policy | There’s been a massive gap in oncology where people who have been responsible for a dramatic increase in the standard of care have lacked a solid understanding of the business, payment and policy constructs required to deliver it. Dr. Stephen Schleicher has spent the early part of his career working to fill that gap. Dr. Schleicher entered medical school with an interest in oncology, anchored by an appreciation for the psychological toll cancer can have on a person, their family and caregive... | 48m 19s | ||||||
| 12/12/24 | ![]() Election Implications (Part 4): Forecasting For Healthcare As The Second Trump Administration Takes Shape | Elements of the new Trump administration are coming into focus as announcements of key healthcare appointments and nominations provide indications for what the market can expect starting in January. To dissect the impact these changes might have, Wall Street Analyst Jeff Garro joined Keith Figlioli to wrap up a four-part series of episodes on election implications. Previous episodes featured conversations with JP Morgan’s Lisa Gill, Canaccord Genuity’s Richard Close, and Maverick Health Polic... | 36m 09s | ||||||
| 11/21/24 | ![]() Election Implications (Part 3): JP Morgan’s Read on Trump 2.0 and What’s Next for Healthcare | Healthcare was not a major focus during the 2024 election where other key issues drove most of the discussion. This left a vacuum around specific healthcare policies and what to expect from a second Trump Administration. With few details available and political capital to spend from the ‘red sweep’ this election, healthcare stakeholders are pondering how much of the incoming administration’s preference for disrupting the status quo will extend to the healthcare industry. For the third episod... | 45m 44s | ||||||
| 10/30/24 | ![]() Election Implications (Part 2): This Wall Street Analyst Agrees, “Healthcare is Hard” | With the White House and Congress up for grabs this election, anticipation in the healthcare industry is high. Shifts in healthcare policy will influence how care is paid for and delivered, which will of course influence the flow of investment dollars in both public and private markets. During the first episode of a four-part series on election implications, beltway insider Julie Barnes laid out potential scenarios for the direction healthcare policy might take depending on election outcomes.... | 30m 42s | ||||||
| 9/26/24 | ![]() Election Implications (Part 1): Angst, Uncertainty and an Urge for Calm from Maverick Health Policy’s Julie Barnes | Julie Barnes has made a career helping health plans, tech vendors, investors and others in the healthcare space decipher health policy. She’s a former Hill staffer who earned her law degree and spent a decade in corporate law serving healthcare clients before moving to policy think tanks, business consulting, and founding Maverick Health Policy. At Maverick, she provides strategic advice on federal health policy to private companies and industry coalitions, with particular focus on health dat... | 45m 42s | ||||||
| 8/29/24 | ![]() What’s the Difference Between Innovation and Performance Improvement? | OSF HealthCare stands as a model health system for those who want to do innovation right. One of the defining characteristics of the Peoria, Illinois-based system is how it aligns innovation with operations for everyone – all 24,000 employees across 159 locations, including 16 hospitals. Becky Buchen is responsible for driving innovation at OSF HealthCare. As SVP of Innovation Operations she works to engage and educate people on the innovation process, leveraging the eco-system for innovatio... | 38m 00s | ||||||
| 7/18/24 | ![]() Help or Harm? How CHAI is Mitigating the Risk of AI in Healthcare | With great power comes great responsibility and in healthcare, those words may have never held more meaning than they do with the advent of artificial intelligence. AI most certainly has the power to transform healthcare, and those in the industry working to develop and use it have an immense responsibility to shape principles that ensure these technologies help, not harm. The Coalition for Health AI (CHAI) was created with a mission to be the trusted source of responsible AI in health that ... | 54m 30s | ||||||
| 6/20/24 | ![]() Live from DHIS East: Mass General Brigham CIO, Christopher Coburn | Chris Coburn has been driving health system innovation for decades. He is currently chief innovation officer at Mass General Brigham (MGB), the nation’s largest academic research enterprise with over $16 billion in annual revenue, 1.5 million patient visits and more than $2.4 billion in research expenditures. MGB also has a managed care organization, out-patient facilities and community hospitals. 7,000 of its faculty are appointed at Harvard Medical School. As head of innovation, Chris lead... | 44m 17s | ||||||
| 5/23/24 | ![]() Reinventing Pharmacy (Part 3): Optum Rx CEO, Dr. Patrick Conway, Brings the PBM, Provider and Payer POV | Optum Rx serves more than 62 million people, processes 1.6 billion prescriptions and generates more than $110 billion of revenue annually. Dr. Patrick Conway, CEO of Optum Rx, is the third and final guest in a series of Healthcare is Hard episodes exploring the transformation of the pharmacy business – following conversations with Mark Cuban and Dr. Troyen Brennan. Dr. Conway brings an expansive view of the healthcare system to this discussion and his role leading one of the most influential... | 40m 32s | ||||||
Showing 25 of 90
Sponsor Intelligence
Sign in to see which brands sponsor this podcast, their ad offers, and promo codes.
Chart Positions
1 placement across 1 market.
Chart Positions
1 placement across 1 market.

























